Author

Taryn N. Beckman

University of ChicagoORCID 0000-0002-4634-3856Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Ani SolankiiD· 2 shared Jeffrey A. HubbelliD· 2 shared Joseph W. RedaiD· 2 shared Lisa R. VolpattiiD· 2 shared Mindy NguyeniD· 2 shared Abigail L. LauterbachiD· 1 shared Brendan Thomas Kane Berg· 1 shared Colleen FoleyiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ani SolankiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 14, 2026

Albumin-fused interleukin-10 prevents experimental autoimmune encephalomyelitis by promoting immunoregulation in the secondary lymphoid organs

Erica Budina, Joseph W. Reda, Kirsten C. Refvik…·Jeffrey A. Hubbell

This study shows that albumin-fused IL-10 reduces experimental autoimmune encephalomyelitis by enhancing immunoregulation in secondary lymphoid organs.

DOI 10.64898/2026.04.10.717764

mousebulk RNA-seq

𝕏 PostBluesky

BioengineeringNature Biomedical EngineeringPeer-reviewedJan 2, 2026

LDL-Binding IL-10 Reduces Vascular Inflammation in Atherosclerotic Mice

Lisa R. Volpatti, Salvador Norton De Matos, Gustavo J. Borjas…·Jeffrey A. Hubbell

This paper develops a targeted IL-10 therapy by fusing it with an LDL-binding antibody fragment, showing reduced vascular inflammation in atherosclerotic mice.

9 citationstop 1%

mouseproteomics

𝕏 PostBluesky